BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagare RP, Sneha S, Krishnapriya S, Ramachandran B, Murhekar K, Vasudevan S, Shabna A, Ganesan TS. ALDH1A1+ ovarian cancer stem cells co-expressing surface markers CD24, EPHA1 and CD9 form tumours in vivo. Exp Cell Res 2020;392:112009. [PMID: 32305326 DOI: 10.1016/j.yexcr.2020.112009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Bindhya S, Sidhanth C, Krishnapriya S, Garg M, Ganesan TS. Development and in vitro characterisation of an induced pluripotent stem cell model of ovarian cancer. Int J Biochem Cell Biol 2021;138:106051. [PMID: 34343671 DOI: 10.1016/j.biocel.2021.106051] [Reference Citation Analysis]
2 Li Y, Xun J, Wang B, Ma Y, Zhang L, Yang L, Gao R, Guan J, Liu T, Gao H, Wang X, Zhang Q. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer. J Transl Med 2021;19:429. [PMID: 34656128 DOI: 10.1186/s12967-021-03102-y] [Reference Citation Analysis]
3 Liu Y, Wang G, Zhang J, Chen X, Xu H, Heng G, Chen J, Zhao Y, Li J, Ni Y, Zhang Y, Shan J, Qian C. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia. Stem Cell Res Ther 2021;12:86. [PMID: 33494824 DOI: 10.1186/s13287-021-02155-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Marni R, Chakraborty A, Malla R. Oncogenic tetraspanins: Implications for metastasis, drug resistance, cancer stem cell maintenance and diagnosis of leading cancers in females. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101548] [Reference Citation Analysis]
5 Lucarini G, Molinelli E, Licini C, Rizzetto G, Radi G, Goteri G, Mattioli-Belmonte M, Offidani A, Simonetti O. Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma. Int J Mol Sci 2022;23:4775. [PMID: 35563166 DOI: 10.3390/ijms23094775] [Reference Citation Analysis]
6 Nowacka M, Ginter-Matuszewska B, Świerczewska M, Sterzyńska K, Nowicki M, Januchowski R. Effect of ALDH1A1 Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model. Int J Mol Sci 2022;23:3036. [PMID: 35328460 DOI: 10.3390/ijms23063036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. ALDH1A1 in Cancers: Bidirectional Function, Drug Resistance, and Regulatory Mechanism. Front Oncol 2022;12:918778. [DOI: 10.3389/fonc.2022.918778] [Reference Citation Analysis]